Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 15
Letter
The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models [Letter]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 2,168 | Dovepress* | 2,105+ | 55 | 2,160 | |
| PubMed Central* | 63 | 36 | 99 | ||
| Totals | 2,168 | 91 | 2,259 | ||
| *Since 19 December 2023 | |||||
View citations on PubMed and Google Scholar